Cargando…
Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9466351/ https://www.ncbi.nlm.nih.gov/pubmed/36094632 http://dx.doi.org/10.1007/s00415-022-11353-y |
| _version_ | 1784787973264375808 |
|---|---|
| author | Nicolas, Philippe Marion-Moffet, Hugo Gossez, Morgane Vukusic, Sandra Monneret, Guillaume Marignier, Romain Venet, Fabienne |
| author_facet | Nicolas, Philippe Marion-Moffet, Hugo Gossez, Morgane Vukusic, Sandra Monneret, Guillaume Marignier, Romain Venet, Fabienne |
| author_sort | Nicolas, Philippe |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9466351 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94663512022-09-12 Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies Nicolas, Philippe Marion-Moffet, Hugo Gossez, Morgane Vukusic, Sandra Monneret, Guillaume Marignier, Romain Venet, Fabienne J Neurol Letter to the Editors Springer Berlin Heidelberg 2022-09-12 2023 /pmc/articles/PMC9466351/ /pubmed/36094632 http://dx.doi.org/10.1007/s00415-022-11353-y Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editors Nicolas, Philippe Marion-Moffet, Hugo Gossez, Morgane Vukusic, Sandra Monneret, Guillaume Marignier, Romain Venet, Fabienne Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies |
| title | Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies |
| title_full | Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies |
| title_fullStr | Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies |
| title_full_unstemmed | Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies |
| title_short | Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies |
| title_sort | anti-sars-cov-2 humoral and cellular responses in multiple sclerosis patients treated with anti-cd20 monoclonal antibodies |
| topic | Letter to the Editors |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9466351/ https://www.ncbi.nlm.nih.gov/pubmed/36094632 http://dx.doi.org/10.1007/s00415-022-11353-y |
| work_keys_str_mv | AT nicolasphilippe antisarscov2humoralandcellularresponsesinmultiplesclerosispatientstreatedwithanticd20monoclonalantibodies AT marionmoffethugo antisarscov2humoralandcellularresponsesinmultiplesclerosispatientstreatedwithanticd20monoclonalantibodies AT gossezmorgane antisarscov2humoralandcellularresponsesinmultiplesclerosispatientstreatedwithanticd20monoclonalantibodies AT vukusicsandra antisarscov2humoralandcellularresponsesinmultiplesclerosispatientstreatedwithanticd20monoclonalantibodies AT monneretguillaume antisarscov2humoralandcellularresponsesinmultiplesclerosispatientstreatedwithanticd20monoclonalantibodies AT marignierromain antisarscov2humoralandcellularresponsesinmultiplesclerosispatientstreatedwithanticd20monoclonalantibodies AT venetfabienne antisarscov2humoralandcellularresponsesinmultiplesclerosispatientstreatedwithanticd20monoclonalantibodies |